Embryo transfer
Otherhealthy blastocyst transfer in natural and hormonal cycle
Other names: drug adminstration, clinical controls
NCT Number: NCT02378584
This study evaluates the difference in pregnancy rate transferring a healthy blastocyst in natural or artificial cycle.
Looking for future studies?
Notify Me20 year–42 year
Female
Interventional
Not applicable
European Hospital, Rome, RM, Italy
The aim of the study was to verify the implantation capacity and ongoing pregnancy rate of vitrified warmed euploid blastocyst in natural cycle versus endometrial artificial cycle with gonadotropin-releasing hormone (GnRH-agonist) pituitary suppression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
healthy blastocyst transfer in natural and hormonal cycle
Other names: drug adminstration, clinical controls
Time frame: 12 weeks after embryo transfer
Time frame: term pregnancy delivery
Time frame: 30 weeks beginning from day 21 of the previous cycle day up to the pregnancy test
Assessment of drug cost and the count of clinical visit, laboratory dosages and venous sampling
Time frame: Six weeks beginning on the day of treatment start, on the day of progesterone administration, on the day of blastocyst transfer and the pregnancy test
the psychological questionnaire (HADS) administered on four time point
European Hospital
Other
The Clinical Results After Frozen-thawed Healthy Blastocyst Transfer in Natural Cycle Versus Cycle With Endometrial Preparation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details